Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEUpdatesResults8 Aug 2026

Par Drugs and Chemicals Limited

Updates

Par Drugs and Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting dated 08.08.2026'. The meeting of Board of Directors considered and approved the Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2026. The Board also approved the drafts of advertisements to be published in newspapers regarding the Unaudited Standalone Financial Results. Additionally, the Board took note of Investor grievances report and reviewed the SCORES platform of SEBI to solve the investor compliant till date. The Board also approved the Corporate Governance Report of the Company for the quarter ended 30th June, 2026. Furthermore, the Board considered and approved the Policy on Communication between Statutory Auditor and Those Charged with Governance (TCWG).

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults8 Aug 2026

Krishna Institute of Medical Sciences Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Krishna Institute of Medical Sciences Limited has announced its Q1 FY '27 earnings, with revenue of INR 1,196 crore, a growth of 36.1% year-on-year and 10.3% on quarter-on-quarter basis. EBITDA was INR 240 crore, with a growth of 20.1% year-on-year and 10.9% on quarter-on-quarter basis. PAT was INR 37 crores, with a growth of 11.8% year-on-year and a decline of 9.1% on quarter-on-quarter basis.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults8 Aug 2026

Par Drugs and Chemicals Limited

Outcome of Board Meeting

Par Drugs and Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026. The meeting of Board of Directors of the Company considered, approved and took on record the Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2026 along with Limited Review Report given CA Mira! Mehta, Partner of Sarupria Somani & Associates, Chartered Accountants, Statutory Auditor of the Company. The Board also considered and approved the drafts of advertisements to be published in newspapers regarding Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2026.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults8 Aug 2026

PNC Infratech Limited

Outcome of Board Meeting

PNC Infratech Limited has announced the outcome of its board meeting, which included the approval of unaudited financial results for the quarter ended June 30, 2026, reappointment of statutory auditors, and reappointment of managing directors and independent directors.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults8 Aug 2026

Lumax Industries Limited

Press Release

Lumax Industries Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with a 32.6% year-on-year growth in revenue and a 33.7% year-on-year growth in EBITDA. The company has also made new launches during the quarter and has been awarded several certifications.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults8 Aug 2026

Captain Polyplast Limited

Press Release

Captain Polyplast Limited has reported its unaudited financials for Q1 FY27, with a 16.3% YoY growth in total income and a 26.7% YoY surge in EBITDA. The company has also secured an order worth ₹11.8 crore from MSEDCL for 500 solar pumps under the PM-KUSUM Scheme and commenced production at its new 70,000 sq. ft. manufacturing facility near Ahmedabad, Gujarat.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults8 Aug 2026

Par Drugs and Chemicals Limited

Outcome of Board Meeting

Par Drugs and Chemicals Limited has announced its unaudited standalone financial results for the quarter ended June 30, 2026, and has approved the same at its board meeting. The company has also approved various other matters, including availing forward booking banking facilities, appointing a portfolio manager, and purchasing new motor vehicles for its directors.

Read more →📎 1 attachment
NSEShareholders meetingResults8 Aug 2026

Tijaria Polypipes Limited

Shareholders meeting

Tijaria Polypipes Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 07, 2026, and informed the Exchange regarding voting results.

Read more →📎 1 attachment
NSEInvestor PresentationResults8 Aug 2026

Advanced Enzyme Technologies Limited

Investor Presentation

Advanced Enzyme Technologies Limited has informed the Exchange about Investor Presentation, enclosed is the Earnings Presentation for the quarter ended June 30, 2026. Revenue grew by 2% on y-o-y basis to ₹ 1,859 million in Q1 FY27 from ₹ 1,859 million in Q1 FY26. EBITDA de-grew by 10% to ₹ 510 million in Q1 FY27 from ₹ 632 million in Q4 FY26. PAT decreased to ₹ 386 million in Q1 FY27 from ₹ 453 million in Q4 FY26.

Read more →📎 1 attachment
NSEGeneral UpdatesResults8 Aug 2026

HMA Agro Industries Limited

General Updates

HMA Agro Industries Limited has informed the Exchange about General Updates regarding the disclosure of inter-se transfer of shares among the Promoter and Promoter Group pursuant to Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults8 Aug 2026

Windsor Machines Limited

Outcome of Board Meeting

Windsor Machines Limited has announced the outcome of its Board meeting, where the financial results for the quarter ended June 30, 2026, were considered and approved. The company has also submitted its unaudited standalone and consolidated financial results for the quarter, along with the Limited Review Reports.

Read more →📎 1 attachment
NSEUpdatesResults8 Aug 2026

Bigbloc Construction Limited

Updates

Bigbloc Construction Limited has informed the Exchange regarding Earnings Presentation in respect of Unaudited Financial Results of the Company for the Quarter ended June 30, 2026.

Read more →📎 1 attachment
NSEPress ReleaseResults8 Aug 2026

Advanced Enzyme Technologies Limited

Press Release

Advanced Enzyme Technologies Limited has announced its unaudited financial results for the first quarter ended June 2026, with revenue from operations growing by 2% year-on-year to ₹1,898 million and EBITDA margin standing at 27%. The company's profit after tax de-grew by 5% to ₹386 million, and earnings per share stood at ₹3.31.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults8 Aug 2026

PNC Infratech Limited

Outcome of Board Meeting

PNC Infratech Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has also re-appointed its statutory auditors, managing directors, and independent directors, and fixed the date for its 27th Annual General Meeting.

Read more →📎 1 attachment
NSEAllotment of SecuritiesResults8 Aug 2026

Tracxn Technologies Limited

Allotment of Securities

Tracxn Technologies Limited has informed the Exchange regarding allotment of 6442 securities pursuant to ESOP/ESPS at its meeting held on August 08, 2026. The equity shares so allotted shall rank pari passu with the existing equity shares of the Company. The paid-up share capital of the Company shall stand increased as under: Existing paid up share capital 10,69,18,589; Post Allotment paid up share capital 10,69,25,031.

Read more →📎 1 attachment
NSEShareholders meetingResults8 Aug 2026

MM Forgings Limited

Shareholders meeting

MM Forgings Limited held its 80th Annual General Meeting on August 8, 2026, through video conferencing, where the necessary quorum was present and the meeting was in order. The company adopted the audited standalone and consolidated financial statements and reports for the financial year ended March 31, 2026, and appointed two new directors and ratified the remuneration of the cost auditor.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults8 Aug 2026

Akums Drugs and Pharmaceuticals Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Presentation for Q1 FY27 Investor Meet/Con. Call Updates. The company has registered a healthy revenue growth of over 13% with EBIDTA increasing by more than 30%. The acquisition of Oriflame India's Manufacturing business is expected to expand the company's manufacturing footprint in skincare cosmetics and wellness products.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults8 Aug 2026

Banco Products (I) Limited

Outcome of Board Meeting

Banco Products (India) Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors also approving the appointment of a new director and cost auditor, and scheduling the 65th Annual General Meeting for September 19, 2026.

Read more →📎 1 attachment
← PreviousPage 1072 of 1569Next →